Christopher M DeGiorgio

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Trigeminal nerve stimulation for epilepsy
    Christopher M DeGiorgio
    Department of Neurology, Geffen School of Medicine at UCLA, Los Angeles, USA
    Neurology 61:421-2. 2003
  2. ncbi request reprint Neurocysticercosis in the United States: review of an important emerging infection
    Christopher M DeGiorgio
    Neurology 64:1486; author reply 1486. 2005
  3. doi request reprint n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 13:681-4. 2008
  4. doi request reprint Neurostimulation for drug-resistant epilepsy
    Christopher M DeGiorgio
    Department of Neurology, David Geffen UCLA School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095, USA
    Continuum (Minneap Minn) 19:743-55. 2013
  5. pmc Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy
    Christopher M DeGiorgio
    Departments of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Neurology 80:786-91. 2013
  6. doi request reprint Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures
    Christopher M DeGiorgio
    Department of Neurology, School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
    Epilepsy Behav 18:322-4. 2010
  7. ncbi request reprint Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA
    C DeGiorgio
    Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Acta Neurol Scand 111:84-8. 2005
  8. ncbi request reprint Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms
    C DeGiorgio
    UCLA Geffen School of Medicine, Los Angeles, CA, USA
    Neurology 65:317-9. 2005
  9. ncbi request reprint Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial
    Christopher M DeGiorgio
    UCLA Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Epilepsia 47:1213-5. 2006
  10. doi request reprint Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Neurosurg Clin N Am 22:449-56, v. 2011

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Trigeminal nerve stimulation for epilepsy
    Christopher M DeGiorgio
    Department of Neurology, Geffen School of Medicine at UCLA, Los Angeles, USA
    Neurology 61:421-2. 2003
  2. ncbi request reprint Neurocysticercosis in the United States: review of an important emerging infection
    Christopher M DeGiorgio
    Neurology 64:1486; author reply 1486. 2005
  3. doi request reprint n-3 fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: clues from a pilot, double-blind, exploratory study
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 13:681-4. 2008
    ....
  4. doi request reprint Neurostimulation for drug-resistant epilepsy
    Christopher M DeGiorgio
    Department of Neurology, David Geffen UCLA School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90095, USA
    Continuum (Minneap Minn) 19:743-55. 2013
    ..The purpose of this review is to provide an evidence-based update on the neurostimulation options available for patients with drug-resistant epilepsy in the United States and in European countries...
  5. pmc Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy
    Christopher M DeGiorgio
    Departments of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Neurology 80:786-91. 2013
    ....
  6. doi request reprint Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures
    Christopher M DeGiorgio
    Department of Neurology, School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA
    Epilepsy Behav 18:322-4. 2010
    ..The literature regarding LCM-related cardiac death and arrhythmia is discussed. Physicians should be aware of the potential cardiac effects of this novel antiepileptic drug...
  7. ncbi request reprint Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA
    C DeGiorgio
    Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
    Acta Neurol Scand 111:84-8. 2005
    ..solium Taeniasis in an at-risk community in the USA, specifically rural Southern California; identify T. solium Taeniasis positive individuals, and treat positive individuals for the tapeworm T. solium Taeniasis...
  8. ncbi request reprint Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms
    C DeGiorgio
    UCLA Geffen School of Medicine, Los Angeles, CA, USA
    Neurology 65:317-9. 2005
    ..The results indicate that the three duty-cycles were equally effective. The data support the use of standard duty-cycles as initial therapy...
  9. ncbi request reprint Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial
    Christopher M DeGiorgio
    UCLA Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Epilepsia 47:1213-5. 2006
    ..Four (57%) of seven subjects who completed >or=3 months experienced a >or=50% reduction in seizure frequency. The results of this pilot study support further investigation into the safety and efficacy of TNS for epilepsy...
  10. doi request reprint Trigeminal nerve stimulation: seminal animal and human studies for epilepsy and depression
    Christopher M DeGiorgio
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Neurosurg Clin N Am 22:449-56, v. 2011
    ..In humans thus far the technique has been applied noninvasively, and is termed external trigeminal nerve stimulation (eTNSTM)...
  11. pmc RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory
    Christopher M DeGiorgio
    Department of Neurology, David Geffen UCLA School of Medicine, Los Angeles, CA 90095, USA
    Epilepsy Behav 19:78-81. 2010
    ..The goal of this study was to determine if specific measures of heart rate variability (HRV) are associated with the total score on a new seven-item inventory for sudden unexplained death in epilepsy (SUDEP)...
  12. doi request reprint Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study
    Ian A Cook
    UCLA Depression Research and Clinic Program, Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, CA, USA
    Epilepsy Behav 28:221-6. 2013
    ..01; effect sizes d 1.0-1.8), as did quality of life (p < 0.02). Four of the 11 achieved remission. These improvements from nightly adjunctive eTNS in treatment-resistant depression merit replication under double-blind conditions...
  13. doi request reprint Acute and long-term safety of external trigeminal nerve stimulation for drug-resistant epilepsy
    Juliana Pop
    Department of Neurology, Olive View Internal Medicine Program, UCLA School of Medicine, Los Angeles, CA 90095, USA
    Epilepsy Behav 22:574-6. 2011
    ..The data indicate that eTNS of the infraorbital and supraorbital branches of the trigeminal nerve is safe and well tolerated...
  14. doi request reprint Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial
    Lara M Schrader
    David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Epilepsy Behav 22:475-8. 2011
    ..This novel neuromodulation approach may have use as an adjunct to pharmacotherapy in major depressive disorder. Additional larger trials are needed to delineate efficacy and tolerability with greater reliability...
  15. ncbi request reprint Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use
    Christi Heck
    USC Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Neurology 59:S31-7. 2002
    ..Finally, we provide an algorithm for the adjustment of VNS device settings (see Appendices)...
  16. ncbi request reprint Deaths associated with cysticercosis. Report of three cases and review of the literature
    Christopher M DeGiorgio
    Department of Neurology, University of California, Los Angeles, California 91342, USA
    Neurosurg Focus 12:e2. 2002
    ..The most common causes of death appear to be 1) intracranial hypertension in surgically treated patients and 2) shunt infection...